Cite
HARVARD Citation
Bisceglia, I. et al. (n.d.). P140 EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING NON–PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS AT HIGH CARDIOVASCULAR RISK: A SINGLE–CENTER EXPERIENCE. European heart journal supplements. p. . [Online].